IDentif.AI-Omicron: Harnessing an AI-Derived and Disease-Agnostic Platform to Pinpoint Combinatorial Therapies for Clinically Actionable Anti-SARS-CoV-2 Intervention

Author:

Blasiak Agata12ORCID,Truong Anh T. L.1ORCID,Wang Peter1ORCID,Hooi Lissa3,Chye De Hoe4,Tan Shi-Bei1,You Kui1ORCID,Remus Alexandria1ORCID,Allen David Michael567ORCID,Chai Louis Yi Ann67,Chan Conrad E.Z.48,Lye David C. B.68910,Tan Gek-Yen G.4,Seah Shirley G. K.4,Chow Edward Kai-Hua123,Ho Dean12

Affiliation:

1. Department of Biomedical Engineering, College of Design and Engineering, National University of Singapore, 117583, Singapore

2. Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, 117600, Singapore

3. Cancer Science Institute of Singapore, National University of Singapore, 117599, Singapore

4. Defence Medical and Environmental Research Institute, DSO National Laboratories, 117510, Singapore

5. Infectious Diseases Translational Research Program, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, 117545, Singapore

6. Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, 119228, Singapore

7. Division of Infectious Disease, Department of Medicine, National University Hospital, 119074, Singapore

8. National Centre for Infectious Diseases (NCID), Jalan Tan Tock Seng, 308442, Singapore

9. Lee Kong Chian School of Medicine, Nanyang Technological University, 308232, Singapore

10. Department of Infectious Diseases, Tan Tock Seng Hospital, 308433, Singapore

Funder

Micron Foundation

National Medical Research Council

Ministry of Education - Singapore

National Research Foundation Singapore

National University of Singapore

Ministry of Defence, Singapore

Sun Life Singapore

Yong Loo Lin School of Medicine

Publisher

American Chemical Society (ACS)

Subject

General Physics and Astronomy,General Engineering,General Materials Science

Reference59 articles.

1. The Anti-COVID-19 Drug Remdesivir Promotes Oncogenic Herpesvirus Reactivation through Regulation of Intracellular Signaling Pathways

2. Laday, J. Sotrovimab No Longer Authorized to Treat COVID-19 in Areas with High BA.2 Frequency. Healio. https://www.healio.com/news/rheumatology/20220325/sotrovimab-no-longer-authorized-to-treat-covid19-in-areas-with-high-ba2-frequency (accessed 2022-04-23).

3. The Potential of Intentional Drug Development

4. Can drugs reduce the risk of long COVID? What scientists know so far

5. Rapid Relapse of Symptomatic Omicron SARS-CoV-2 Infection Following Early Suppression with Nirmatrelvir/Ritonavir

Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3